MethylDetect, Author at MethylDetect

Our assay helps to identify cancer predisposition – Lynch Syndrome

UncategorizedBy MethylDetect November 9, 2018

MethylDetect’s assay targetting MLH1 gene is now a part of the NICE-mandated Lynch Syndrome pre-screen test. The results showing the performance of our MLH1 methylation testing assays, performed in collaboration with Sarah Cannon Molecular Diagnostics, https://sarahcannon-md.co.uk , were presented at the National Cancer Research Institute conference 2018. see: MLH1 Promoter Hypermethylation: Development and Preliminary Validation of a Methylation-Specific High…

Proud to be one of the finalists of SCALE-UP Denmark National Finale 2018

FeaturedBy MethylDetect September 29, 2018

WHEN: 1 NOVEMBER14.00-18.00 WHERE: SAV VÆRKET, ÅRHUS, Søren Nymarks Vej 8A, 8270 Højbjerg FOR MORE INFO visit: https://mgra08.wixsite.com/scaleupdenmarkfinale

Methyldetect’s CEO Tomasz K Wojdacz invited to give a talk at High Tech Summit powered by DTU (Technical University of Denmark)

UncategorizedBy MethylDetect September 29, 2018

Business Talk: “Molecular Biomarkers – a key to personalized medicine” by Tomasz K. Wojdacz, CEO, MethylDetect ApS in session: Biomarkers – The key to personalised health (Organised by Med Tech Innovation & Biopeople) for more info see: https://www.tilmeld.dk/HighTechSummit2018/programme.html

MethylDetect ApS featured in September profile of the month at BIOPEOPLE

FeaturedBy MethylDetect September 25, 2018

Interview about what we do, methylation biomarkers, our current product, technology (MS-HRM) and future IVD (in-vitro diagnostic) plans. see more at: https://biopeople.eu/news/show/september-profile-methyldetect/

Methyldetect’s Co-Founder A/Professor LL Hansen invited to give a talk at 4BIO Summit: Europe

UncategorizedBy MethylDetect September 8, 2018

qPCR & Digital PCR Congress, 27th-28th Nov 2018, Rotterdam, Netherlands EXPLORING ADVANCES IN TECHNOLOGY AND RESEARCH IN QPCR, DPCR/NGS, MICROFLUIDICS & GENE EDITING Talk title: Methylation-Sensitive High-Resolution Melting (MS-HRM) for sensitive DNA methylation assessment for details see: http://www.global-engage.com/event/4bio-qpcr/#register

Visit us at 4BIO Summit 2018, 27th-28th Nov 2018, Rotterdam, Netherlands

FeaturedBy MethylDetect August 29, 2018

We are one of the sponsors and will exhibit at 4BIO Summit: Europe, 27th-28th Nov 2018, Rotterdam, Netherlands for more info: http://www.global-engage.com/event/4bio/

We have qualified to Accelerace program – Europe’s leading seen accelerator

FeaturedBy MethylDetect September 30, 2017

For the next year we will be developing or business with the advicers from the Europe’s leading seen accelerator Methyl Detect

Talk To MethylDetect At Danish Ip Fair On May 9th

FeaturedBy MethylDetect August 25, 2017

We will be at the Danish IP Fair on May 9th, with the intention to meet anyone interested in learning, and possibly using, our MS-HRM and cancer biomarker IP. There are all kinds of opportunities that we are open to discussion on. For example: Can you use MS-HRM in your own R&D? Would MS-HRM assays add value…

Nature Biotechnology Publication on DNA Methylation Assays, Including MS-HRM

MS-HRMBy MethylDetect July 18, 2016

Follow this link, or click on the picture to read how MS-HRM compares in a thorough and wide-ranging study of DNA methylation assays, published in Nature Biotechnology:

Author Archives: MethylDetect

Get in Touch